URRARO, TERESA
 Distribuzione geografica
Continente #
NA - Nord America 868
EU - Europa 821
AS - Asia 119
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 1.810
Nazione #
US - Stati Uniti d'America 867
PL - Polonia 490
IT - Italia 124
IE - Irlanda 80
SE - Svezia 72
CN - Cina 43
HK - Hong Kong 28
DE - Germania 23
JO - Giordania 20
VN - Vietnam 17
FI - Finlandia 16
ES - Italia 6
SG - Singapore 6
GB - Regno Unito 4
KR - Corea 4
FR - Francia 3
AU - Australia 1
CA - Canada 1
EU - Europa 1
IN - India 1
MD - Moldavia 1
NL - Olanda 1
RU - Federazione Russa 1
Totale 1.810
Città #
Warsaw 490
Fairfield 141
Dublin 80
Chandler 74
Seattle 74
Ashburn 72
Woodbridge 66
Wilmington 62
Houston 57
Cambridge 55
Altamura 30
Florence 30
Beijing 25
Lawrence 25
Princeton 23
Bremen 17
Buffalo 17
Ann Arbor 14
Hong Kong 14
Medford 13
Dong Ket 10
New York 10
San Diego 8
Barcelona 6
Boardman 6
Shanghai 6
Boston 5
Falls Church 5
Norwalk 5
Cagliari 4
Empoli 4
Prato 4
Avigliano 3
Old Bridge 3
Singapore 3
Aachen 2
Arezzo 2
Bastia umbra 2
Hillsboro 2
Munich 2
Phoenix 2
Poggibonsi 2
Redwood City 2
San Piero A Sieve 2
Washington 2
Andover 1
Brisbane 1
Chisinau 1
Chiswick 1
Düsseldorf 1
Fucecchio 1
Guangzhou 1
Hanoi 1
Incisa 1
Jacksonville 1
Jesi 1
Jiaxing 1
Kilburn 1
Laurel 1
Los Angeles 1
Messina 1
Milan 1
New Bedfont 1
Ponte 1
Pune 1
Quercegrossa 1
Rotterdam 1
Seoul 1
Siena 1
Terracina 1
Toronto 1
Totale 1.507
Nome #
Analisi della risposta al trattamento con triplice terapia (peg-IFN alfa+RBV+DAA) in pazienti con infezione cronica da HCV genotipo 1, con e senza crioglobulinemia mista (CM) 265
Role of MicroRNA Profile Modifications in Hepatitis C Virus-Related Mixed Cryoglobulinemia 220
Assessment of liver stiffness in patients with HCV and mixed cryoglobulinemia undergoing rituximab treatment. 195
Assessment of free light chains in HCV-positive patients with mixed cryoglobulinaemia vasculitis undergoing rituximab treatment 124
Interferon-free therapy in hepatitis C virus mixed cryoglobulinaemia: a prospective, controlled, clinical and quality of life analysis 123
Combined treatment with antiviral therapy and rituximab in patients with mixed cryoglobulinemia: review of the literature and report of a case using direct antiviral agents-based antihepatitis C virus therapy 119
Hepatitis B virus related cryoglobulinemic vasculitis: A multicentre open label study from the Gruppo Italiano di Studio delle Crioglobulinemie - GISC 113
Retreatment regimen of rituximab monotherapy given at the relapse of severe HCV-related cryoglobulinemic vasculitis: Long-term follow up data of a randomized controlled multicentre study 110
Prospective study of guideline-tailored therapy with direct-acting antivirals for hepatitis C virus-associated mixed cryoglobulinemia 105
Long-term effect of HCV eradication in patients with mixed cryoglobulinemia: A prospective, controlled, open-label, cohort study. 98
Triple antiviral therapy in hepatitis C virus infection with or without mixed cryoglobulinaemia: A prospective, controlled pilot study. 72
microRNA PROFILE MODIFICATIONS IN HEPATITIS C VIRUS-RELATED MIXED CRYOGLOBULINEMIA 65
Could the presence of Mixed Cryoglobulinemia influence the outcome of standard peg-IFN plus ribavirin anti-HCV therapy? 53
Response to IFN-based antiviral therapy and long term effect of HCV eradication in Mixed Cryoglobulinemia, with or without symptoms: a prospective, controlled, open-label, long term, cohort study 46
ETIOLOGICAL THERAPY IN HCV-RELATED MIXED CRYOGLOBULINEMIA SYNDROME: THE ROLE OF IL28B GENOTYPE AS PREDICTOR OF RESPONSE 42
HCV-related lymphatic and hepatic malignancies are associated with different microRNA expression patterns in PBMCs 38
Safety and effectiveness of boceprevir triple therapy in patients with mixed cryoglobulinemia 35
Totale 1.823
Categoria #
all - tutte 4.586
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.586


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020391 26 34 11 30 50 42 41 45 41 33 38 0
2020/2021331 20 15 14 57 19 29 17 24 24 77 16 19
2021/2022139 0 7 13 7 6 10 5 8 8 11 21 43
2022/2023381 31 69 26 30 25 73 46 20 49 0 7 5
2023/2024118 3 22 21 3 6 28 1 19 1 2 4 8
2024/202522 22 0 0 0 0 0 0 0 0 0 0 0
Totale 1.823